Lipoprotein lipase and endothelial lipase expression in mouse brain: Regional distribution and selective induction following kainic acid-induced lesion and focal cerebral ischemia

Neurobiology of Disease

Volumn 15, Issue 2, 2004, Pages 312-325

  Paradis, E ^a   Clavel, S ^a   Julien, P ^b   Murthy, M R V ^a   De Bilbao, F ^c,d   Arsenijevic, D ^e   Giannakopoulos, P ^c,d   Vallet, P ^c   Richard, D ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^e ETH ZURICH   (Switzerland)

Author keywords

Excitotoxicity; In situ hybridization; Ischemia; Lipase; Lipid; MRNA distribution

Indexed keywords

ENDOTHELIAL LIPASE; KAINIC ACID; LIPOPROTEIN LIPASE; MESSENGER RNA; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN NERVE CELL; BRAIN REGION; BRAIN THIRD VENTRICLE; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ANALYSIS; EPENDYMA CELL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HIPPOCAMPUS; INJECTION; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEOCORTEX; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PYRAMIDAL NERVE CELL; PYRIFORM CORTEX; RNA ANALYSIS; THALAMUS; UPREGULATION;

ANIMALS; BRAIN; BRAIN ISCHEMIA; CEREBRAL CORTEX; CEREBRAL INFARCTION; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HIPPOCAMPUS; INFARCTION, MIDDLE CEREBRAL ARTERY; KAINIC ACID; LIPASE; LIPOPROTEIN LIPASE; MALE; MICE; MICE, INBRED C57BL; NERVE DEGENERATION; NEUROTOXINS; PYRAMIDAL CELLS; REACTION TIME; RNA, MESSENGER; UP-REGULATION;

EID: 1542300727     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2003.09.017     Document Type: Article

References (53)

1. Aronow B.J., Lund S.D., Brown T.L., Harmony J.A., Witte D.P. Apolipoprotein J expression at fluid-tissue interfaces: potential role in barrier cytoprotection. Proc. Natl. Acad. Sci. U. S. A. 90:1993;725-729.
2. Baum L., Chen L., Masliah E., Chan Y.S., Ng H.K., Pang C.P. Lipoprotein lipase mutations and Alzheimer's disease. Am. J. Med. Genet. 88:1999;136-139.
3. Baum L., Wiebusch H., Pang C.P. Roles for lipoprotein lipase in Alzheimer's disease: an association study. Microsc. Res. Tech. 50:2000;291-296.
4. Beffert U., Danik M., Krzywkowski P., Ramassamy C., Berrada F., Poirier J. The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer's disease. Brain Res. Brain Res. Rev. 27:1998;119-142.
5. Braun J.E.A., Severson D.L. Regulation of the synthesis, processing and translocation of lipoprotein lipase. Biochemistry. 287:1992;337-347.
6. Chait A., Robertson T., Brunzell J.D. Chylomicronemia syndrome and diabetes mellitus. Diabetes Care. 4:1981;343-348.
7. Danik M., Champagne D., Petit-Turcotte C., Beffert U., Poirier J. Brain lipoprotein metabolism and its relation to neurodegenerative disease. Crit. Rev. Neurobiol. 13:1999;357-407.
8. De Bilbao F., Guarin E., Nef P., Vallet P., Giannakopoulos P., Dubois-Dauphin M. Cell death is prevented in thalamic fields but not in injured neocortical areas after permanent focal ischaemia in mice overexpressing the anti-apoptotic protein Bcl-2. Eur. J. Neurosci. 12:2000;921-934.
9. Derewenda Z.S. Structure and function of lipases. Adv. Protein Chem. 45:1994;1-52.
10. Farooqui A.A., Horrocks L.A. Excitatory amino acid receptors, neural membrane phospholipid metabolism and neurological disorders. Brain Res. Brain Res. Rev. 16:1991;171-191.
11. Farooqui A.A., Horrocks L.A. Excitotoxicity and neurological disorders: involvement of membrane phospholipids. Int. Rev. Neurobiol. 36:1994;267-323.
12. Gander R., Eller P., Kaser S., Theurl I., Walter D., Sauper T., Ritsch A., Patsch J.R., Foger B. Molecular characterization of rabbit phospholipid transfer protein: choroid plexus and ependyma synthesize high levels of phospholipid transfer protein. J. Lipid Res. 43:2002;636-645.
13. Goff D.C., Coyle J.T. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am. J. Psychiatry. 158:2001;1367-1377.
14. Hirata K., Dichek H.L., Cioffi J.A., Choi S.Y., Leeper N.J., Quintana L., Kronmal G.S., Cooper A.D., Quertermous T. Cloning of a unique lipase from endothelial cells extends the lipase gene family. J. Biol. Chem. 274:1999;14170-14175.
15. Huey P.U., Waugh K.C., Etienne J., Eckel R.H. Lipoprotein lipase is expressed in rat sciatic nerve and regulated in response to crush injury. J. Lipid Res. 43:2002;19-25.
16. Ito D., Tanaka K., Suzuki S., Dembo T., Fukuuchi Y. Enhanced expression of Iba1, ionized calcium-binding adapter molecule 1, after transient focal cerebral ischemia in rat brain. Stroke. 32:2001;1208-1215.
17. Jaye M., Lynch K.J., Krawiec J., Marchadier D., Maugeais C., Doan K., South V., Amin D., Perrone M., Rader D.J. A novel endothelial-derived lipase that modulates HDL metabolism. Nat. Genet. 21:1999;424-428.
18. Kida E., Pluta R., Lossinsky A.S., Golabek A.A., Choi-Miura N.H., Wisniewski H.M., Mossakowski M.J. Complete cerebral ischemia with short-term survival in rat induced by cardiac arrest. II. Extracellular and intracellular accumulation of apolipoproteins E and J in the brain. Brain Res. 674:1995;341-346.
19. Kieburtz K. Antiglutamate therapies in Huntington's disease. J. Neural. Transm., Suppl. 55:1999;97-102.
20. Kim D.-H., Iijima H., Goto K., Sakai J., Ishii H., Kim H.-J., Suzuki H., Kondo H., Saeki S., Yamamoto T. Human apolipoprotein E receptor 2. J. Biol. Chem. 271:1996;8373-8380.
21. Koch S., Donarski N., Goetze K., Kreckel M., Stuerenburg H.J., Buhmann C., Beisiegel U. Characterization of four lipoprotein classes in human cerebrospinal fluid. J. Lipid Res. 42:2001;1143-1151.
22. Kristian T., Siesjo B.K. Calcium in ischemic cell death. Stroke. 29:1998;705-718.
23. Kubota M., Kitahara S., Narita K., Tamura A., Sano K., Shimasaki H., Ueta N. Changes in cerebral free fatty acids and triacylglycerols in focal cerebral ischemia. Int. J. Biochem. 22:1990;1269-1272.
24. LaDu M.J., Gilligan S.M., Lukens J.R., Cabana V.G., Reardon C.A., Van Eldik L.J., Holtzman D.M. Nascent astrocyte particles differ from lipoproteins in CSF. J. Neurochem. 70:1998;2070-2081.
25. Lorent K., Overbergh L., Moechars D., De Strooper B., Van Leuven F., Van Den Berghe H. Expression in mouse embryos and in adult mouse brain of three members of the amyloid precursor protein family, of the alpha-2-macroglobulin receptor/low density lipoprotein receptor-related protein and of its ligands apolipoprotein E, lipoprotein lipase, alpha-2-macroglobulin and the 40. 000 molecular weight receptor-associated protein Neuroscience. 65:1995;1009-1025.
26. March P.A. Seizures: classification, etiologies, and pathophysiology. Clin. Tech. Small Anim. Pract. 13:1998;119-131.
27. Martin-Rehrmann M.D., Cho H.S., Rebeck G.W. Lack of association of two lipoprotein lipase polymorphisms with Alzheimer's disease. Neurosci. Lett. 328:2002;109-112.
28. Mauch D.H., Nagler K., Schumacher S., Goritz C., Muller E.C., Otto A., Pfrieger F.W. CNS synaptogenesis promoted by glia-derived cholesterol. Science. 294:2001;1354-1357.
29. Nunez M., Peinado-Onsurbe J., Vilaro S., Llobera M. Lipoprotein lipase activity in developing rat brain areas. Biol. Neonate. 68:1995;119-127.
30. Olivecrona G., Olivecrona T. Triglyceride lipases and atherosclerosis. Curr. Opin. Lipidol. 6:1995;291-305.
31. Olivecrona T., Olivecrona G. Lipoprotein and hepatic lipase in lipoprotein metabolism. Betteridge D.J., Illingworth D.R., Shepperd J. Lipoproteins in Health and Disease. 1999;222-246 Oxford Univ. Press, New York.
32. Ong W.Y., He Y., Suresh S., Patel S.C. Differential expression of apolipoprotein D and apolipoprotein E in the kainic acid-lesioned rat hippocampus. Neuroscience. 79:1997;359-367.
33. Paradis E., Clement S., Julien P., Ven Murthy M.R. Lipoprotein lipase affects the survival and differentiation of neural cells exposed to very low density lipoprotein. J. Biol. Chem. 278:2003;9698-9705.
34. Pitas R.E., Boyles J.K., Lee S.H., Hui D., Weisgraber K.H. Lipoproteins and their receptors in the central nervous system. J. Biol. Chem. 262:1987;14352-14360.
35. Plaitakis A., Shashidharan P. Glutamate transport and metabolism in dopaminergic neurons of substantia nigra: implications for the pathogenesis of Parkinson's disease. J. Neurol. 247(Suppl. 2):2000;II25-II35.
36. Poirier J., Baccichet A., Dea D., Gauthier S. Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats. Neuroscience. 55:1993;81-90.
37. Postuma R.B., Martins R.N., Cappai R., Beyreuther K., Masters C.L., Strickland D.K., Mok S.S., Small D.H. Effects of the amyloid protein precursor of Alzheimer's disease and other ligands of the LDL receptor-related protein on neurite outgrowth from sympathetic neurons in culture. FEBS Lett. 428:1998;13-16.
38. Rader D.J., Jaye M. Endothelial lipase: a new member of the triglyceride lipase gene family. Curr. Opin. Lipidol. 11:2000;141-147.
39. Rebeck G.W., Harr S.D., Strickland D.K., Hyman B.T. Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the alpha 2-macroglobulin receptor/low-density-lipoprotein receptor-related protein. Ann. Neurol. 37:1995;211-217.
40. Roheim P.S., Carey M., Forte T., Vega G.L. Apolipoproteins in human cerebrospinal fluid. Proc. Natl. Acad. Sci. U. S. A. 76:1979;4646-4649.
41. Santamarina-Fojo S., Dugi K.L. Structure, function and role of lipoprotein lipase in lipoprotein metabolism. Curr. Opin. Lipidol. 5:1994;117-125.
42. Sheng H., Laskowitz D.T., Mackensen G.B., Kudo M., Pearlstein R.D., Warner D.S. Apolipoprotein E deficiency worsens outcome from global cerebral ischemia in the mouse. Stroke. 30:1999;1118-1124.
43. Siesjo B.K. Pathophysiology and treatment of focal cerebral ischemia. Part II: mechanisms of damage and treatment. J. Neurosurg. 77:1992;337-354.
44. Simmons D.M., Arriza J.L., Swanson L.W. A complete protocol for in-situ hybridization of messenger RNAs in brain and other tissues with radio-labelled single stranded RNA probes. J. Histochem. 12:1989;169-181.
45. Sugiyama T., Kumagai H., Morikawa Y., Wada Y., Sugiyama A., Yasuda K., Yokoi N., Tamura S., Kojima T., Nosaka T., Senba E., Kimura S., Kadowaki T., Kodama T., Kitamura T. A novel low-density lipoprotein receptor-related protein mediating cellular uptake of apolipoprotein E-enriched beta-VLDL in vitro. Biochemistry. 39:2000;15817-15825.
46. Sun G.Y., Lu F.L., Lin S.E., Ko M.R. Decapitation ischemia-induced release of free fatty acids in mouse brain. Relationship with diacylglycerols and lysophospholipids. Mol. Chem. Neuropathol. 17:1992;39-50.
47. Tikka T., Fiebich B.L., Goldsteins G., Keinanen R., Koistinaho J. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J. Neurosci. 21:2001;2580-2588.
48. Vilaro S., Camps L., Reina M., Perez-Clausell J., Llobera M., Olivecrona T. Localization of lipoprotein lipase to discrete areas of the guinea pig brain. Brain Res. 506:1990;249-253.
49. Xu Q., Li Y., Cyras C., Sanan D.A., Cordell B. Isolation and characterization of apolipoproteins from murine microglia. Identification of a low density lipoprotein-like apolipoprotein J-rich but E-poor spherical particle. J. Biol. Chem. 275:2000;31770-31777.
50. Yacoub L.K., Vanni T.M., Goldberg I.J. Lipoprotein lipase mRNA in neonatal and adult mouse tissues: comparison of normal and combined lipase deficiency (cld) mice assessed by in situ hybridization. J. Lipid Res. 31:1990;1845-1852.
51. Yates P.O. Vascular disease of the central nervous system. Blackwood W., Corsellis J.A.N. Greenfield's Neuropathology. third edition:1976;Edward Arnold, London.
52. Yoshida S., Ikeda M., Busto R., Santiso M., Martinez E., Ginsberg M.D. Cerebral phosphoinositide, triacylglycerol, and energy metabolism in reversible ischemia: origin and fate of free fatty acids. J. Neurochem. 47:1986;744-757.
53. Zhang J.P., Sun G.Y. Free fatty acids, neutral glycerides, and phosphoglycerides in transient focal cerebral ischemia. J. Neurochem. 64:1995;1688-1695.